← Eichor
Condition: High Grade Intraepithelial Neoplasia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: High Grade Intraepithelial Neoplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
Phase 1 · 1 location(s) · Lindsay Ferguson, MD · NCT06191133
Lopinavir/Ritonavir in PLWH With High-Grade AIN
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT05334004
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
NA · 8 location(s) · Universitair Ziekenhuis Brussel · NCT07029152
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396
Implementation of Anal Cancer Screening and Treatment in Nigeria
NA · 1 location(s) · University of Maryland, Baltimore · NCT05817370
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical I
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT04057924
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Phase N/A · 3 location(s) · Proteocyte Diagnostics Inc. · NCT04622462
Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
Phase N/A · 1 location(s) · University of Pretoria · NCT02956031
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk
NA · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT06052033
Screening Women With Prior HPV for Anal Neoplasia
NA · 3 location(s) · Icahn School of Medicine at Mount Sinai · NCT05217940
Comparison of pCLE and EB in Gastric Lesion Diagnosis
NA · 1 location(s) · Huazhong University of Science and Technology · NCT06389448
Safety of Anal Curcumin
Phase 1 · 2 location(s) · Lisa Flowers · NCT06626230
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NA · 1 location(s) · Timser SAPI de CV · NCT07480902
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
Phase N/A · 20 location(s) · Fujian Maternity and Child Health Hospital · NCT05282095
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · 15 location(s) · Catharina Ziekenhuis Eindhoven · NCT05405270
Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
Phase N/A · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT04783805
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
Phase N/A · 5 location(s) · Changhai Hospital · NCT07117045
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HS
Phase 2 · 5 location(s) · Frantz Viral Therapeutics, LLC · NCT06075264
Effect of Honey For CIN II
Phase 1/Phase 2 · 2 location(s) · Zuyderland Medisch Centrum · NCT06219018
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Phase N/A · 5 location(s) · Proteocyte Diagnostics Inc. · NCT05853783
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.